ARCHIVES

NMP22 Assay More Effective Than Conventional Lab Test

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent

December 27, 2013

R01 Grants Pool, New Investigators Hit By Budget Strains

October 27, 1989

ACS Prostate Cancer Screening Guideline Urges Doctor-Patient Informed Decision

March 5, 2010

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

February 3, 2006

In Brief: ACR to Move From Chicago To Washington D.C. Area; Hanks Astro President, Phillips President Elect

December 16, 1983

Five-year Childhood ALL Survival Increased To 90.4 Percent by 2005

March 30, 2012